author-photo

Heidi H. Gillenwater

University of North Carolina at Chapel Hill

12

Papers

609

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (305)
6525 POSTER Phase II study investigating the efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC)

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC): Results from a phase II study

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (37)
Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (99)
O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

2003 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

2002 Seminars in Radiation Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

2002 Cancer
Show All
- Source
- Cite
- Save
Citations (16)
Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing

2001 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (33)
Second-Line Gemcitabine in Refractory Stage IV Non-Small-Cell Lung Cancer: A Phase II Trial

2000 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (18)
Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.

1999 Cancer Investigation
Show All
- Source
- Cite
- Save
Citations (48)